vs
Side-by-side financial comparison of JBG SMITH Properties (JBGS) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $127.6M, roughly 1.3× JBG SMITH Properties). JBG SMITH Properties runs the higher net margin — -35.7% vs -82.0%, a 46.3% gap on every dollar of revenue. On growth, JBG SMITH Properties posted the faster year-over-year revenue change (-2.5% vs -22.7%). Over the past eight quarters, JBG SMITH Properties's revenue compounded faster (-6.3% CAGR vs -11.5%).
JBG SMITH PropertiesJBGSEarnings & Financial Report
JBG SMITH Properties is a publicly traded real estate investment trust based in Bethesda, Maryland.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
JBGS vs PTCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $127.6M | $164.7M |
| Net Profit | $-45.5M | $-135.0M |
| Gross Margin | — | — |
| Operating Margin | -47.5% | -43.3% |
| Net Margin | -35.7% | -82.0% |
| Revenue YoY | -2.5% | -22.7% |
| Net Profit YoY | 24.0% | -104.8% |
| EPS (diluted) | $-0.76 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $127.6M | $164.7M | ||
| Q3 25 | $123.9M | $211.0M | ||
| Q2 25 | $126.5M | $178.9M | ||
| Q1 25 | $120.7M | $1.2B | ||
| Q4 24 | $130.8M | $213.2M | ||
| Q3 24 | $136.0M | $196.8M | ||
| Q2 24 | $135.3M | $186.7M | ||
| Q1 24 | $145.2M | $210.1M |
| Q4 25 | $-45.5M | $-135.0M | ||
| Q3 25 | $-28.6M | $15.9M | ||
| Q2 25 | $-19.2M | $-64.8M | ||
| Q1 25 | $-45.7M | $866.6M | ||
| Q4 24 | $-59.9M | $-65.9M | ||
| Q3 24 | $-27.0M | $-106.7M | ||
| Q2 24 | $-24.4M | $-99.2M | ||
| Q1 24 | $-32.3M | $-91.6M |
| Q4 25 | -47.5% | -43.3% | ||
| Q3 25 | -27.5% | 1.4% | ||
| Q2 25 | -18.4% | -19.5% | ||
| Q1 25 | -44.7% | 82.5% | ||
| Q4 24 | -53.6% | -76.2% | ||
| Q3 24 | -22.4% | -27.7% | ||
| Q2 24 | -24.3% | -21.5% | ||
| Q1 24 | -30.1% | -21.6% |
| Q4 25 | -35.7% | -82.0% | ||
| Q3 25 | -23.1% | 7.5% | ||
| Q2 25 | -15.2% | -36.3% | ||
| Q1 25 | -37.9% | 73.7% | ||
| Q4 24 | -45.8% | -30.9% | ||
| Q3 24 | -19.8% | -54.2% | ||
| Q2 24 | -18.0% | -53.1% | ||
| Q1 24 | -22.2% | -43.6% |
| Q4 25 | $-0.76 | $-1.63 | ||
| Q3 25 | $-0.48 | $0.20 | ||
| Q2 25 | $-0.29 | $-0.83 | ||
| Q1 25 | $-0.56 | $10.04 | ||
| Q4 24 | $-0.70 | $-0.85 | ||
| Q3 24 | $-0.32 | $-1.39 | ||
| Q2 24 | $-0.27 | $-1.29 | ||
| Q1 24 | $-0.36 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $75.3M | $1.9B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $-205.3M |
| Total Assets | $4.4B | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $75.3M | $1.9B | ||
| Q3 25 | $64.4M | $1.7B | ||
| Q2 25 | $61.4M | $2.0B | ||
| Q1 25 | $81.3M | $2.0B | ||
| Q4 24 | $145.8M | $1.1B | ||
| Q3 24 | $137.0M | $1.0B | ||
| Q2 24 | $163.5M | $1.1B | ||
| Q1 24 | $220.5M | $884.8M |
| Q4 25 | $1.2B | $-205.3M | ||
| Q3 25 | $1.2B | $-155.8M | ||
| Q2 25 | $1.3B | $-206.5M | ||
| Q1 25 | $1.6B | $-185.8M | ||
| Q4 24 | $1.8B | $-1.1B | ||
| Q3 24 | $1.9B | $-1.1B | ||
| Q2 24 | $2.0B | $-980.2M | ||
| Q1 24 | $2.1B | $-893.9M |
| Q4 25 | $4.4B | $2.9B | ||
| Q3 25 | $4.4B | $2.6B | ||
| Q2 25 | $4.5B | $2.6B | ||
| Q1 25 | $4.7B | $2.7B | ||
| Q4 24 | $5.0B | $1.7B | ||
| Q3 24 | $5.2B | $1.8B | ||
| Q2 24 | $5.3B | $1.9B | ||
| Q1 24 | $5.4B | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $73.3M | $-34.3M |
| Free Cash FlowOCF − Capex | — | $-36.6M |
| FCF MarginFCF / Revenue | — | -22.3% |
| Capex IntensityCapex / Revenue | — | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $73.3M | $-34.3M | ||
| Q3 25 | $8.9M | $-66.3M | ||
| Q2 25 | $18.8M | $-58.3M | ||
| Q1 25 | $12.9M | $870.1M | ||
| Q4 24 | $129.4M | $-30.0M | ||
| Q3 24 | $26.4M | $-77.0M | ||
| Q2 24 | $23.8M | $-71.5M | ||
| Q1 24 | $37.0M | $70.8M |
| Q4 25 | — | $-36.6M | ||
| Q3 25 | — | $-69.7M | ||
| Q2 25 | — | $-59.6M | ||
| Q1 25 | — | $868.4M | ||
| Q4 24 | — | $-33.8M | ||
| Q3 24 | — | $-77.5M | ||
| Q2 24 | — | $-78.8M | ||
| Q1 24 | — | $61.2M |
| Q4 25 | — | -22.3% | ||
| Q3 25 | — | -33.1% | ||
| Q2 25 | — | -33.3% | ||
| Q1 25 | — | 73.8% | ||
| Q4 24 | — | -15.8% | ||
| Q3 24 | — | -39.4% | ||
| Q2 24 | — | -42.2% | ||
| Q1 24 | — | 29.1% |
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 1.8% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 4.0% | ||
| Q1 24 | — | 4.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | -4.17× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
